EE397 Health and Budget Impact of Liquid Biopsy (LBx)-Based Comprehensive Genomic Profiling (CGP) in Patients With Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC)
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.693
https://www.valueinhealthjournal.com/article/S1098-3015(24)00808-8/fulltext
Title :
EE397 Health and Budget Impact of Liquid Biopsy (LBx)-Based Comprehensive Genomic Profiling (CGP) in Patients With Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00808-8&doi=10.1016/j.jval.2024.03.693
First page :
Section Title :
Open access? :
No
Section Order :
10170